Document is current

Any future updates will be listed below

Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel

Crossref DOI link: https://doi.org/10.1038/s41598-024-65689-8

Published Online: 2024-07-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark